Related references
Note: Only part of the references are listed.CRIM-negative infantile Pompe disease: 42-month treatment outcome
Marianne Rohrbach et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2010)
Temporal neuropathologic and behavioral phenotype of 6neo/6neo Pompe disease mice
Richard L. Sidman et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2008)
Characterization of pre- and post-treatment pathology after enzyme replacement therapy for pompe disease
Beth L. Thurberg et al.
LABORATORY INVESTIGATION (2006)
Brain development in infantile-onset Pompe disease treated by enzyme replacement therapy
Yin-Hsiu Chien et al.
PEDIATRIC RESEARCH (2006)
Poor predictive validity of the Bayley Scales of Infant Development for cognitive function of extremely low birth weight children at school age
M Hack et al.
PEDIATRICS (2005)
Detection of a homozygous D645E mutation of the acid α-glucosidase gene and glycogen deposition in tissues in a second-trimester fetus with infantile glycogen storage disease type II
CP Chen et al.
PRENATAL DIAGNOSIS (2004)
Presidential address. Prediction of function from infancy to early childhood: Implications for pediatric psychology
GP Aylward
JOURNAL OF PEDIATRIC PSYCHOLOGY (2004)
Enzyme replacement and enhancement therapies for lysosomal diseases
RJ Desnick
JOURNAL OF INHERITED METABOLIC DISEASE (2004)
Intractable fever and cortical neuronal glycogen storage in glycogenosis type 2
C Martini et al.
NEUROLOGY (2001)
Share Paper
